| ADAMTS1 | CDKN2A | CRABP1 | HOXA9 | MAL | MGMT | MLH1 | NR3C1 | RUNX3 | SCGB3A1 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | M | U | M | U | M | U | M | U | M | U | M | U | M | U | M | U | M | U | M | U |
Sample type | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
N1 | 0 | 21 | 0 | 21 | 0 | 21 | 4 | 17 | 1 | 20 | 2 | 19 | 0 | 21 | 0 | 21 | 0 | 1 | 1 | 20 |
N2 | 1 | 17 | 2 | 16 | 0 | 18 | 7 | 11 | 2 | 16 | 7 | 10 | 1 | 17 | 0 | 18 | 0 | 1 | 1 | 17 |
Adenoma | 23 | 40 | 10 | 53 | 7 | 53 | 22 | 40 | 45 | 18 | 23 | 39 | 0 | 63 | 2 | 61 | 4 | 4 | 4 | 59 |
Carcinomas | 36 | 15 | 17 | 35 | 25 | 25 | 12 | 38 | 41 | 9 | 21 | 31 | 11 | 41 | 13 | 37 | 16 | 9 | 9 | 40 |
MSI status | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Carcinomas | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
MSI | 19 | 8 | 10 | 17 | 22 | 5 | 7 | 20 | 21 | 6 | 11 | 16 | 11 | 16 | 12 | 15 | 16 | 8 | 8 | 18 |
MSS | 17 | 7 | 7 | 18 | 3 | 20 | 5 | 18 | 20 | 2 | 10 | 15 | 0 | 25 | 1 | 22 | 0 | 1 | 1 | 22 |
P value | NS | NS | <0.0001 | NS | NS | NS | <0.0001 | 0.001 | <0.0001 | 0.026 |